Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Aubagne, France | March 24, 2026
At today’s combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A., shareholders granted discharge to all Directors by a large majority.
Effective March 24, 2026, the Board of Directors of Sartorius Stedim Biotech S.A. is composed of: Michael Grosse (Chairman), René Fáber (CEO), Pascale Boissel, Susan Dexter, Cécile Dussart, Abdelatif Zeroual (Director Representing Employees), Anne-Marie Graffin (Lead Independent Director), Lothar Kappich, and Christopher Nowers.
The shareholders also approved all other resolutions by a large majority, including the proposal to pay a dividend of 0.69 euros per share for fiscal 2025. The total payout will be 67.1 million euros. The dividend will be paid as from April 2, 2026.
Further Information
